Maternal use of antibiotics and the risk of orofacial clefts: A nationwide cohort study

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 3, 2012, Pages 246-253

  Mølgaard Nielsen, Ditte ^a   Hviid, Anders ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

Antibiotics during pregnancy; Birth defects; Drug safety

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; DICLOXACILLIN; DOXYCYCLINE; ERYTHROMYCIN; NITROFURANTOIN; ORAL CONTRACEPTIVE AGENT; PENICILLIN V; PIVAMPICILLIN; PIVMECILLINAM; ROXITHROMYCIN; SULFAMETHIZOLE; TETRACYCLINE; TRIMETHOPRIM;

ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CLEFT LIP; CLEFT PALATE; COHORT ANALYSIS; DENMARK; DIARRHEA; DRUG USE; EDUCATIONAL STATUS; FEMALE; FEVER; FIRST TRIMESTER PREGNANCY; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MATERNAL SMOKING; OUTCOME ASSESSMENT; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; URINARY TRACT INFECTION; VITAMIN SUPPLEMENTATION;

ANTI-BACTERIAL AGENTS; CLEFT LIP; CLEFT PALATE; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DENMARK; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; INFANT, NEWBORN; MATERNAL EXPOSURE; ODDS RATIO; PREGNANCY; PREGNANCY TRIMESTERS; PREVALENCE; REGISTRIES; RISK;

EID: 84858279452     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2179     Document Type: Article

References (32)

1. Olesen C, Steffensen FH, Nielsen GL, de Jong-van den Berg L, Olsen J, Sorensen HT. Drug use in first pregnancy and lactation: a population-based survey among Danish women. The EUROMAP Group. Eur J Clin Pharmacol 1999; 55: 139-144.
2. Crider KS, Cleves MA, Reefhuis J, Berry RJ, Hobbs CA, Hu DJ. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med 2009; 163: 978-985.
3. Czeizel AE, Rockenbauer M. Teratogenic study of doxycycline. Obstet Gynecol 1997; 89: 524-528.
4. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study. Reprod Toxicol 2001; 15: 637-646.
5. Kallen B. Maternal drug use and infant cleft lip/palate with special reference to corticoids. Cleft Palate Craniofac J 2003; 40: 624-628.
6. Puho EH, Szunyogh M, Metneki J, Czeizel AE. Drug treatment during pregnancy and isolated orofacial clefts in Hungary. Cleft Palate Craniofac J 2007; 44: 194-202.
7. Saxen I. Associations between oral clefts and drugs taken during pregnancy. Int J Epidemiol 1975; 4: 37-44.
8. Mossey P. Epidemiology underpinning research in the aetiology of orofacial clefts. Orthod Craniofac Res 2007; 10: 114-120.
9. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull 1998; 45: 320-323.
10. Jorgensen FS. Ultrasonography of pregnant women in Denmark 1999-2000. Description of the development since 1980-1990. Ugeskr Laeger 2003; 165: 4409-4415.
11. The Danish Medicines Agency. About the Register of Medicinal Product Statistics. [4 January 2011].
12. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263-268.
13. Robert E, Kallen B, Harris J. The epidemiology of orofacial clefts. 1. Some general epidemiological characteristics. J Craniofac Genet Dev Biol 1996; 16: 234-241.
14. Yang J, Carmichael SL, Canfield M, Song J, Shaw GM. Socioeconomic status in relation to selected birth defects in a large multicentered US case-control study. Am J Epidemiol 2008; 167: 145-154.
15. Wyszynski DF, Duffy DL, Beaty TH. Maternal cigarette smoking and oral clefts: a meta-analysis. Cleft Palate Craniofac J 1997; 34: 206-210.
16. Metneki J, Puho E, Czeizel AE. Maternal diseases and isolated orofacial clefts in Hungary. Birth Defects Res A Clin Mol Teratol 2005; 73: 617-623.
17. Erickson JD. Risk factors for birth defects: data from the Atlanta Birth Defects Case-Control Study. Teratology 1991; 43: 41-51.
18. Leite IC, Paumgartten FJ, Koifman S. Chemical exposure during pregnancy and oral clefts in newborns. Cad Saúde Pública 2002; 18: 17-31.
19. Saxen I. The association between maternal influenza, drug consumption and oral clefts. Acta Odontol Scand 1975; 33: 259-267.
20. Sivertsen A, Wilcox AJ, Skjaerven R et al. Familial risk of oral clefts by morphological type and severity: population based cohort study of first degree relatives. BMJ 2008; 336: 432-434.
21. Olsen J, Melbye M, Olsen SF et al. The Danish National Birth Cohort-its background, structure and aim. Scand J Public Health 2001; 29: 300-307.
22. Cedergren M, Kallen B. Maternal obesity and the risk for orofacial clefts in the offspring. Cleft Palate Craniofac J 2005; 42: 367-371.
23. Bille C, Olsen J, Vach W et al. Oral clefts and life style factors-a case-cohort study based on prospective Danish data. Eur J Epidemiol 2007; 22: 173-181.
24. Badovinac RL, Werler MM, Williams PL, Kelsey KT, Hayes C. Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Res A Clin Mol Teratol 2007; 79: 8-15.
25. Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT. Oral phenoxymethylpenicillin treatment during pregnancy. Results of a population-based Hungarian case-control study. Arch Gynecol Obstet 2000; 263: 178-181.
26. Institute for Rational Pharmacotherapy. List of national recommendation, Antibiotics (systemic use). [4 January 2011].
27. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. A population-based case-control teratologic study of oral erythromycin treatment during pregnancy. Reprod Toxicol 1999; 13: 531-536.
28. De-Regil LM, Fernandez-Gaxiola AC, Dowswell T, Pena-Rosas JP. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev 2010; CD007950.
29. Johnson CY, Little J. Folate intake, markers of folate status and oral clefts: is the evidence converging? Int J Epidemiol 2008; 37: 1041-1058.
30. Larsen H, Nielsen GL, Bendsen J, Flint C, Olsen J, Sorensen HT. Predictive value and completeness of the registration of congenital abnormalities in three Danish population-based registries. Scand J Public Health 2003; 31: 12-16.
31. Statens Serum Institut, Danish Veterinary and Food Administration, Danish Medicines Agency, National Veterinary Institute, Technical University of Denmark, and National Food Institute, Technical University of Denmark. DANMAP2008 - Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. Vibeke Frøkjær Jensen and Anette M.Hammerum. [4 January 2011].
32. Beaty TH, Wang H, Hetmanski JB et al. A case-control study of nonsyndromic oral clefts in Maryland. Ann Epidemiol 2001; 11: 434-442.